SNDX

• 2026-06-10 share offering or dilution eventfreshOpen filing ↗
  “…transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the…”
  +1 more passage from the same document

  • “…even as new information becomes available. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No.…”
• 2026-06-04 share offering or dilution eventfreshOpen filing ↗
  “…of the Exchange Act. ☐ Item 1.01 Entry into a Material Agreement. Indenture and Notes On June 3, 2026, Syndax Pharmaceuticals, Inc.…”
  +1 more passage from the same document

  • “…no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new…”
• 2026-06-04 capital return (buybacks/dividends)freshOpen filing ↗
  “…to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.…”
  +1 more passage from the same document

  • “…plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund will be provided for the Notes. If the…”
• 2026-04-30 share offering or dilution eventrecentOpen filing ↗
  “…may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be…”
  +1 more passage from the same document

  • “…that we would otherwise prefer to develop and market ourselves. At-the-Market Offering Program In May 2023, we entered into a…”
• 2026-04-30 capital return (buybacks/dividends)recentOpen filing ↗
  “…payments, including the grant of a back-up security interest in the purchased royalties and certain assets related to the product…”
  +1 more passage from the same document

  • “…interest in the purchased royalties and certain assets related to the product and restrictions on the incurrence of additional…”

Recorded SEC filings in plain language — not advice or a prediction.